These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 19176129)

  • 1. [Recent advances in studies of clinical treatment of uveitis].
    Zheng YZ
    Zhonghua Yan Ke Za Zhi; 2008 Oct; 44(10):952-5. PubMed ID: 19176129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biologics in the treatment of uveitis.
    Imrie FR; Dick AD
    Curr Opin Ophthalmol; 2007 Nov; 18(6):481-6. PubMed ID: 18163000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Options and strategy for the treatment of chronic endogenous uveitis].
    Garweg JG
    Klin Monbl Augenheilkd; 2007 Apr; 224(4):367-72. PubMed ID: 17458817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [EBM analysis: classic DMARDs (disease-modifying antirheumatic drugs) and immunosuppressants in arthritis and uveitis].
    Niehues T; Winterhalter S; Zierhut M; Michels H; Becker MD; Heiligenhaus A
    Klin Monbl Augenheilkd; 2007 Jun; 224(6):520-5. PubMed ID: 17594624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrospective case review of pediatric patients with uveitis treated with infliximab.
    Rajaraman RT; Kimura Y; Li S; Haines K; Chu DS
    Ophthalmology; 2006 Feb; 113(2):308-14. PubMed ID: 16406545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonsteroidal drugs for the treatment of noninfectious posterior and intermediate uveitis.
    Imrie FR; Dick AD
    Curr Opin Ophthalmol; 2007 May; 18(3):212-9. PubMed ID: 17435428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The treatment of recurrent uveitis with TNF-alpha inhibitors].
    Falappone PC; Iannone F; Scioscia C; Grattagliano V; Covelli M; Lapadula G
    Reumatismo; 2004; 56(3):185-9. PubMed ID: 15470524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TNFalpha-blocking agents or conventional immunosuppressive drugs in the therapy of children with uveitis? - an evidence based approach.
    Winterhalter S; Niehues T
    Klin Padiatr; 2008; 220(6):342-7. PubMed ID: 18949668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapy of intermediate uveitis].
    Doycheva D; Deuter C; Zierhut M
    Ophthalmologe; 2014 Dec; 111(12):1219-32; quiz 1233-4. PubMed ID: 25448321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A clinical approach to the medical treatment of uveitis.
    Luntz MH
    Adv Ophthalmol; 1978; 36():187-96. PubMed ID: 665406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Recent advances in clinical and basic studies of uveitis in China in the last five years].
    Yang PZ; Xing L
    Zhonghua Yan Ke Za Zhi; 2005 Aug; 41(8):743-7. PubMed ID: 16191333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of tumor necrosis factor inhibitors in uveitis.
    Rabinovich CE
    Curr Opin Rheumatol; 2007 Sep; 19(5):482-6. PubMed ID: 17762615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Advances in uveitis study].
    Yang PZ
    Zhonghua Yan Ke Za Zhi; 2005 Dec; 41(12):1149-52. PubMed ID: 16409776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of biologic agents in the management of uveitis.
    Trivedi A; Katelaris C
    Intern Med J; 2019 Nov; 49(11):1352-1363. PubMed ID: 30582273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Behçet's disease: an open-label trial.
    Tugal-Tutkun I; Mudun A; Urgancioglu M; Kamali S; Kasapoglu E; Inanc M; Gül A
    Arthritis Rheum; 2005 Aug; 52(8):2478-84. PubMed ID: 16052571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Uveitis. A status assessment].
    Arocker-Mettinger E; Grabner G
    Fortschr Ophthalmol; 1990; 87 Suppl():S110-7. PubMed ID: 2083890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Inhibitors of tumour necrosis factor-alpha for the treatment of arthritis and uveitis in childhood].
    Heiligenhaus A; Horneff G; Greiner K; Mackensen F; Zierhut M; Foeldvari I; Michels H
    Klin Monbl Augenheilkd; 2007 Jun; 224(6):526-31. PubMed ID: 17594625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effectiveness of etanercept and infliximab in the treatment of ocular inflammation.
    Galor A; Perez VL; Hammel JP; Lowder CY
    Ophthalmology; 2006 Dec; 113(12):2317-23. PubMed ID: 16996615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of Behçet's disease--an update.
    Kaklamani VG; Kaklamanis PG
    Semin Arthritis Rheum; 2001 Apr; 30(5):299-312. PubMed ID: 11303303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-TNF therapies in the management of acute and chronic uveitis.
    Hale S; Lightman S
    Cytokine; 2006 Feb; 33(4):231-7. PubMed ID: 16542849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.